compounded tirzepatide frozen TrimRX See if you qualify. Compounded Tirzepatide - Big Easy

Together, these actions provide a comprehensive approach to diabetes management

Quickstart Highlights GHK-Cu (glycyl-L-histidyl-L-lysine:copper complex) is a naturally occurring copper peptide with documented roles in wound healing, tissue remodeling, and skin regeneration [1] [2]

Failed Attempts: Multiple drugs (Selonsertib, Cenicriviroc, Elafibranor) failed Phase 3 NASH trials because they: Targeted single pathways (inflammation or fibrosis) Didn't address root cause (obesity, insulin resistance) Showed biomarker improvements but not biopsy-proven NASH resolution Retatrutide's Advantage: Addresses root metabolic dysfunction (28.7% weight loss) Proven up to 82.4% liver fat reduction (Phase 2a) Inflammation resolution (enzyme normalization) Multi-pathway hepatic benefits Probability of Success: Higher than previous NASH drug candidates, but biopsy-proven efficacy still needs confirmation

However, researchers soon realised its potential therapeutic use in humans as an anticoagulant